An NIHR Health Technology Assessment (HTA) funded trial comparing optimised multiple insulin injection therapy (using rapid and twice daily long-acting insulin analogues) with continuous subcutaneous insulin infusion (CSII) in adult type 1 diabetic patients provided with high quality DAFNE structured education.

Patient course curriculum and resources development is complete.  Educator training started, due for completion in January 2012.

The trial has been registered on the ISRCTN register (ISRCTN61215213) and publicly displayed on the ISRCTN website http://www.controlled-trials.com/ISRCTN61215213/

 

Commencement:                              Starting recruitment on 1st November 2011

Centres involved:                               7 (plus one reserve)

No of patients to be recruited:         280 (140 MDI and 140 CSII)

Completion due date:   December 2015


Last Updated: 24/10/2011